Skip to main contentAI and Advanced
/
SUDARSHAN · BSEBSE SENSEX77,294.91-0.10%BSE |
NIFTY 5024,171.65-0.20%NSE |
NIFTY BANK57,360.3-0.29%NSE |
NIFTY IT30,474.95-0.40%NSE |
NIFTY AUTO29,017.2-0.29%NSE |
NIFTY FMCG47,370.85-0.33%NSE |
NIFTY PHARMA26,404.9+0.25%NSE |
NIFTY 50023,479.1-0.14%NSE |
SU
BSE · Equity shares · Specialty Chemicals1.33 · 3.48%
Sudarshan Pharma Industries Ltd SUDARSHAN
NSE:Not available
BSE:INR 39.5
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsAvailable · provider snapshot
Research sections8 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for SUDARSHAN
Analysis, reports, chat and Advanced access use the same ShareKeyX account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 38.17
Day rangeINR 37 — INR 40.07
52-week rangeINR 30.7 — INR 42.48
Volume6.24 L
Market cap993.64
P/E28.91
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)358.18
Net Income (INR Cr)13.85
P/E Ratio28.91
EPS0.58
Research path: Interpret Sudarshan Pharma Industries Ltd's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
SUDARSHANSudarshan Pharma Industries Ltd1d · INR · BSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
BSE reported results · INR crore
| Metric | Mar-26 | Sep-25 | FY25-26 |
|---|---|---|---|
| Revenue | 358.18 | 309.32 | 667.5 |
| Net Profit | 13.85 | 8.13 | 21.98 |
| EPS | 0.58 | 0.34 | 0.91 |
| Cash EPS | 0.65 | 0.4 | 1.05 |
| OPM % | 9.49 | 7.56 | 8.6 |
| NPM % | 3.87 | 2.63 | 3.29 |
Fundamentals
Valuation and ratios
Margins
Operating Margin 12m9.49
Net Profit Margin 12m3.87
Valuation
Price to Sale Ratio2.77
Risk and consensus
Source-qualified signals
Risk metrics
Risk metrics unavailable.
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
Peer data unavailable in the company profile payload.
Shareholding
Ownership
- Promoter and promoter group
- 58.93%
- Public shareholders
- 41.07%
- Other shareholders
- 0.00%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Announcement under Regulation 30 (LODR)-AllotmentBSE corporate filing · 19 Aug 2026, 5:30 am
Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE corporate filing · 18 Aug 2026, 5:30 am
Announcement under Regulation 30 (LODR)-Investor PresentationBSE corporate filing · 18 Aug 2026, 5:30 am
FCCB Committee Meeting On Wednesday, 19-August-2026BSE corporate filing · 14 Aug 2026, 5:30 am
Announcement under Regulation 30 (LODR)-Investor PresentationBSE corporate filing · 14 Aug 2026, 5:30 am
Announcement under Regulation 30 (LODR)-AcquisitionBSE corporate filing · 13 Aug 2026, 5:30 am
Corporate actions
Events
- board MeetingsResults
- board MeetingsResults
- corporate ActionsFinal Dividend 0.30
- corporate ActionsStock Split From Rs.10/- to Rs.1/-
- board MeetingsGeneral
- board MeetingsA.G.M.
- board MeetingsResults
- board MeetingsGeneral
ShareKeyX Community
Discussion and sentiment for Sudarshan Pharma Industries Ltd
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and ShareKeyX AI.
Checking your ShareKeyX account…
Company profile
Business information
What the company does
Not available
Company facts
- Industry
- Specialty Chemicals
- Sector
- Commodities
- Website
- www.sudarshanpharma.com
- Address
- 301, Aura Biplex Above Kalyan Jewellers, 3rd Floor, S. V. Road, , Mumbai, Maharashtra, 400092
- NSE Code
- SUDARSHAN
- BSE Code
- 543828
- Listing date
- 22 Mar 2023
- Face value
- 1
- Market lot
- 4,000
- CIN
- L51496MH2008PLC184997
- Company email
- compliance@sudarshanpharma.com
- Company phone
- 022-42221111
Leadership and officers
- Executive Director-Chairperson-MD
- Mr. Hemal Vasantrai Mehta
- Executive Director-MD
- Mr. Sachin Vasantrai Mehta
- Non-Executive - Independent Director
- Mrs. Jaya Ankur Singhania
- Non-Executive - Independent Director
- Mr. Rushabh Prashant Patil
- Non-Executive - Non Independent Director
- Mr. Anil Balkrishna Ghogare
- Non-Executive - Independent Director
- Mr. Vijay Ojha
- Non-Executive - Non Independent Director
- Mr. Vinay Kumar Pandey
- Non-Executive - Independent Director
- Mr. Sanat Bhat
- Chief Financial Officer
- Mr. Sharad Kathawate
- Company Secretary & Compliance Officer
- Mr. Nirav Kishor Shah
Questions
Stock FAQ
What is the symbol and ISIN of Sudarshan Pharma Industries Ltd?
Sudarshan Pharma Industries Ltd has the symbol SUDARSHAN and ISIN - INE00TV01023.
What is the current price of Sudarshan Pharma Industries Ltd?
Sudarshan Pharma Industries Ltd is currently trading at INR 39.50.
What are the year high and year low of Sudarshan Pharma Industries Ltd?
Sudarshan Pharma Industries Ltd has a year high of INR 42.48 and a year low of INR 30.70.
What is the market capitalization of Sudarshan Pharma Industries Ltd?
Sudarshan Pharma Industries Ltd has a market capitalization of INR 993.64 crore.
What is the P/E ratio of Sudarshan Pharma Industries Ltd?
Sudarshan Pharma Industries Ltd has a P/E ratio of 28.91.
What is the dividend yield of Sudarshan Pharma Industries Ltd?
Sudarshan Pharma Industries Ltd has a dividend yield of NA.
How is the financial performance of Sudarshan Pharma Industries Ltd based on revenue, net income, and EPS?
Sudarshan Pharma Industries Ltd has revenue of INR 358.18 crore, net income of INR 13.85 crore, and EPS of NA.
What is the book value of Sudarshan Pharma Industries Ltd?
Sudarshan Pharma Industries Ltd has a book value of NA.
What is the debt-to-equity ratio of Sudarshan Pharma Industries Ltd?
Sudarshan Pharma Industries Ltd has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Sudarshan Pharma Industries Ltd?
Sudarshan Pharma Industries Ltd has a price-to-book ratio of NA and a price-to-sales ratio of 2.77.
Corporate-action adjustment is provider-defined. ShareKeyX research and computed indicators are not investment advice.